CA26313-1 - 0x0000000000003988

Study Number: CA26313
Group Number: 1
Study Requirement: Healthy Male
Stipend: $8,350.00

Study Criteria:

  • Age: 19 - 45
  • BMI: 18 - 30
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat liver fibrosis.
  • Route of Administration: Oral
  • Blood Draws: 41

Study Schedule:

  • Schedule Type: Long Term
  • Study Length: One - 31 Night Stay

Screening Dates: (appointments available in Lincoln and Omaha)

Event Day Event Date
Friday 10/19/2018

Doctor Exam Dates: (appointments available in Lincoln and Omaha)

Event Day Event Date
Friday 10/19/2018

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Sunday 10/21/2018 2:00:00 PM Wednesday 11/21/2018 8:30:00 AM 1 Lincoln